AI Portfolio Summary
In 2025 Q4, Defilade Capital Management, L.P. maintained a portfolio of 33 distinct positions. The most significant new addition to the portfolio was PFIZER INC, which now represents 7.44% of the total fund value.
Total Positions
33
Quarter
2025 Q4
Top Holding
PFE (7.4%)
Top 10 Concentration
55.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 33
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PFE
PFIZER INC
|
Unknown | 7.44% | — |
#1
Prev: #—
|
5.0 | 2,203,504 | no change |
NEW
|
2,203,504 | $54,867,250 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABBV
ABBVIE INC
|
Unknown | 7.05% | — |
#2
Prev: #—
|
4.8 | 227,669 | no change |
NEW
|
227,669 | $52,020,090 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVS
NOVARTIS AG
|
Unknown | 6.78% | — |
#3
Prev: #—
|
4.7 | 362,816 | no change |
NEW
|
362,816 | $50,021,442 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ICUI
ICU MED INC
|
Unknown | 6.59% | — |
#4
Prev: #—
|
4.6 | 340,745 | no change |
NEW
|
340,745 | $48,614,089 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PACS
PACS GROUP INC
|
Unknown | 5.96% | — |
#5
Prev: #—
|
4.4 | 1,145,485 | no change |
NEW
|
1,145,485 | $43,975,169 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Unknown | 4.65% | — |
#6
Prev: #—
|
3.9 | 31,950 | no change |
NEW
|
31,950 | $34,336,026 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STE
STERIS PLC
|
Unknown | 4.65% | — |
#7
Prev: #—
|
3.9 | 135,307 | no change |
NEW
|
135,307 | $34,303,031 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Unknown | 4.18% | — |
#8
Prev: #—
|
3.7 | 1,234,634 | no change |
NEW
|
1,234,634 | $30,865,850 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Unknown | 3.92% | — |
#9
Prev: #—
|
3.6 | 363,454 | no change |
NEW
|
363,454 | $28,949,111 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIIB
BIOGEN INC
|
Unknown | 3.86% | — |
#10
Prev: #—
|
3.5 | 161,992 | no change |
NEW
|
161,992 | $28,508,972 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVL
NUVALENT INC
|
Unknown | 3.67% | — |
#11
Prev: #—
|
3.5 | 269,043 | no change |
NEW
|
269,043 | $27,063,035 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Unknown | 3.51% | — |
#12
Prev: #—
|
3.4 | 45,662 | no change |
NEW
|
45,662 | $25,861,130 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HSIC
HENRY SCHEIN IN...
|
Unknown | 3.28% | — |
#13
Prev: #—
|
3.3 | 320,422 | no change |
NEW
|
320,422 | $24,217,495 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GMED
GLOBUS MED INC
|
Unknown | 3.16% | — |
#14
Prev: #—
|
3.3 | 267,212 | no change |
NEW
|
267,212 | $23,330,280 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XNCR
XENCOR INC
|
Unknown | 2.94% | — |
#15
Prev: #—
|
3.2 | 1,414,755 | no change |
NEW
|
1,414,755 | $21,659,899 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Unknown | 2.74% | — |
#16
Prev: #—
|
3.1 | 568,619 | no change |
NEW
|
568,619 | $20,197,347 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALGN
ALIGN TECHNOLOG...
|
Unknown | 2.71% | — |
#17
Prev: #—
|
3.1 | 128,060 | no change |
NEW
|
128,060 | $19,996,569 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Unknown | 2.48% | — |
#18
Prev: #—
|
3.0 | 85,694 | no change |
NEW
|
85,694 | $18,273,389 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Unknown | 2.20% | — |
#19
Prev: #—
|
2.9 | 244,881 | no change |
NEW
|
244,881 | $16,252,752 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BDX
BECTON DICKINSO...
|
Unknown | 2.14% | — |
#20
Prev: #—
|
2.9 | 81,207 | no change |
NEW
|
81,207 | $15,759,842 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATRC
ATRICURE INC
|
Unknown | 2.13% | — |
#21
Prev: #—
|
2.9 | 397,636 | no change |
NEW
|
397,636 | $15,730,480 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LIVN
LIVANOVA PLC
|
Unknown | 2.01% | — |
#22
Prev: #—
|
2.8 | 241,413 | no change |
NEW
|
241,413 | $14,854,142 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATEC
ALPHATEC HLDGS ...
|
Unknown | 1.79% | — |
#23
Prev: #—
|
2.7 | 626,754 | no change |
NEW
|
626,754 | $13,186,904 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNLI
DENALI THERAPEU...
|
Unknown | 1.47% | — |
#24
Prev: #—
|
2.6 | 656,713 | no change |
NEW
|
656,713 | $10,842,332 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GKOS
GLAUKOS CORP
|
Unknown | 1.40% | — |
#25
Prev: #—
|
2.6 | 91,703 | no change |
NEW
|
91,703 | $10,354,186 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 33 holdings